These biomarkers improved prognostic discrimination and patient re-classification for CV death or HF at @ year ( all categorical NRI > @ % , p < @ ) , and maintained independent association with composite CV death or HF when concurrently assessed in a model with clinical indicators plus BNP , cTnI , ST@ , PAPP-A , and MPO ( each p@ @ ) -LSB- corrected -RSB- .